4.6 Article

Spectrum of chronic lung allograft pathology in a mouse minor-mismatched orthotopic lung transplant model

期刊

AMERICAN JOURNAL OF TRANSPLANTATION
卷 19, 期 1, 页码 247-258

出版社

WILEY
DOI: 10.1111/ajt.15167

关键词

basic (laboratory) research/science; bronchiolitis obliterans (BOS); fibrosis; lung (allograft) function/dysfunction; lung transplantation/pulmonology; rejection; rejection: chronic; translational research/science

资金

  1. Cystic Fibrosis Canada [2387]
  2. Parker B Francis Foundation
  3. International Society for Heart and Lung Transplantation

向作者/读者索取更多资源

Chronic lung allograft dysfunction (CLAD) is a fatal condition that limits survival after lung transplantation (LTx). The pathological hallmark of CLAD is obliterative bronchiolitis (OB). A subset of patients present with a more aggressive CLAD phenotype, called restrictive allograft syndrome (RAS), characterized by lung parenchymal fibrosis (PF). The mouse orthotopic single LTx model has proven relevant to the mechanistic study of allograft injury. The minor-alloantigen-mismatched strain combination using C57BL/10(B10) donors and C57BL/6(B6) recipients reportedly leads to OB. Recognizing that OB severity is a spectrum that may coexist with other pathologies, including PF, we aimed to characterize and quantify pathologic features of CLAD in this model. Left LTx was performed in the following combinations: B10 -> B6, B6 -> B10, B6 -> B6. Four weeks posttransplant, blinded pathologic semi-quantitative assessment showed that OB was present in 66% of B10 -> B6 and 30% of B6 -> B10 grafts. Most mice with OB also had PF with a pattern of pleuroparenchymal fibroelastosis, reminiscent of human RAS-related pathology. Grading of pathologic changes demonstrated variable severity of airway fibrosis, PF, acute rejection, vascular fibrosis, and epithelial changes, similar to those seen in human CLAD. These assessments can make the murine LTx model a more useful tool for further mechanistic studies of CLAD pathogenesis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cardiac & Cardiovascular Systems

Clinical features and allograft failure rates of pulmonary antibody-mediated rejection categories

Ananth Charya, Ileana L. Ponor, Adam Cochrane, Deborah Levine, Mary Philogene, Yi-Ping Fu, Moon K. Jang, Hyesik Kong, Pali Shah, Ann Mary Bon, Aravind Krishnan, Joby Mathew, Helen Luikart, Kiran K. Khush, Gerald Berry, Charles Marboe, Aldo Iacono, Jonathan B. Orens, Steven D. Nathan, Sean Agbor-Enoh

Summary: This study aims to define the clinical features and associated outcomes of recently defined antibody-mediated rejection (AMR) categories in lung transplant recipients. Clinical AMR showed a higher risk of allograft failure compared to subclinical or no AMR.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

Article Cardiac & Cardiovascular Systems

Determining the impact of ex-vivo lung perfusion on hospital costs for lung transplantation: A retrospective cohort study

John Kenneth Peel, Shaf Keshavjee, David Naimark, Mingyao Liu, Lorenzo Del Sorbo, Marcelo Cypel, Kali Barrett, Eleanor M. Pullenayegum, Beate Sander

Summary: This study compared the institutional costs of lung transplantation before and after the availability of EVLP and determined the health-economic impact of EVLP. The study found that EVLP availability was associated with faster progression to transplantation without significant marginal cost increase.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

Article Cardiac & Cardiovascular Systems

Triaging donor lungs based on a microaspiration signature that predicts adverse recipient outcome

Rayoun Ramendra, Andrew T. Sage, Jonathan Yeung, Juan C. Fernandez-Castillo, Marcelo Cuesta, Meghan Aversa, Mingyao Liu, Marcelo Cypel, Shaf Keshavjee, Tereza Martinu

Summary: This study investigates the utility of measuring total bile acids (TBA) in donor large airway bronchial wash (LABW) to predict the performance of donor lungs and recipient outcomes.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

Editorial Material Cardiac & Cardiovascular Systems

Natural killer cells, CMV infection, and antibody-mediated rejection

P. Riddell, S. C. Juvet

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

Letter Surgery

Alpha-1-antitrypsin safely promotes rapid recovery of pigs after lung transplantation

Andrea Mariscal, Jussi Tikkanen, Lindsay Calderone, Olivia Hough, Manyin Chen, Tereza Martinu, Stephen Juvet, Marcelo Cypel, Mingyao Liu, Shaf Keshavjee

AMERICAN JOURNAL OF TRANSPLANTATION (2023)

Review Pharmacology & Pharmacy

Applications and safety of gold nanoparticles as therapeutic devices in clinical trials

Leeann Yao, Dejan Bojic, Mingyao Liu

Summary: The use of gold nanoparticles in medicine has vast clinical implications and exciting therapeutic potential. Current studies suggest that there are no major safety concerns with the use of gold nanoparticles, but more research and clinical trials are needed to further understand their safety and efficacy in clinical settings.

JOURNAL OF PHARMACEUTICAL ANALYSIS (2023)

Article Cell Biology

Deficiency of the CD155-CD96 immune checkpoint controls IL-9 production in giant cell arteritis

Shozo Ohtsuki, Chenyao Wang, Ryu Watanabe, Hui Zhang, Mitsuhiro Akiyama, Melanie C. Bois, Joseph J. Maleszewski, Kenneth J. Warrington, Gerald J. Berry, Jorg J. Goronzy, Cornelia M. Weyand

Summary: Loss of function of inhibitory immune checkpoints can lead to autoimmune disease, such as giant cell arteritis (GCA). In this study, a defective CD155-CD96 immune checkpoint was found in GCA patients, resulting in the retention of CD155 in the endoplasmic reticulum (ER) of macrophages. Antigen-presenting cells with low CD155 expression induced the expansion of tissue invasive CD4+CD96+ T cells that released interleukin-9 (IL-9). The dysregulated immune response caused vessel wall destruction, which could be suppressed by anti-IL-9 antibodies in a GCA mouse model.

CELL REPORTS MEDICINE (2023)

Editorial Material Cardiac & Cardiovascular Systems

Remodeling valve-sparing pulmonary root replacement repair of giant pulmonary artery aneurysm

Michael J. Paulsen, Edgar C. Aranda-Michel, Gerald J. Berry, Y. Joseph Woo

JTCVS TECHNIQUES (2023)

Article Biochemistry & Molecular Biology

De Novo Design and Development of a Nutrient-Rich Perfusate for Ex Vivo Lung Perfusion with Cell Culture Models

Lei Huang, Ravi N. Vellanki, Zhiyuan Zhu, Bradly G. Wouters, Shaf Keshavjee, Mingyao Liu

Summary: Ex vivo lung perfusion (EVLP) has improved lung transplant success by evaluating marginal lungs before transplantation. To develop EVLP as a platform for donor lung reconditioning, a prolonged EVLP and new perfusates providing sufficient nutritional support are necessary. A combination of DMEM and a current EVLP perfusate (Steen solution) enhanced cell function and reduced apoptosis. A new EVLP perfusate, D05D7A solution, based on DMEM was designed and tested, showing improved cell function and higher levels of GSH and HSP70 compared to Steen solution. DMEM-based nutrient-rich perfusate could prolong EVLP and improve donor lung quality for transplantation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Medicine, Research & Experimental

Acellular ex vivo lung perfusate silences pro-inflammatory signaling in human lung endothelial and epithelial cells

Jamie E. Jeon, Lei Huang, Zhiyuan Zhu, Aaron Wong, Shaf Keshavjee, Mingyao Liu

Summary: This study investigated the effects of ischemia-reperfusion and ex vivo lung perfusion (EVLP) on gene expression in human pulmonary microvascular endothelial cells and epithelial cells. The results showed that both cell types exhibited changes in gene expressions after ischemia-reperfusion or EVLP, with the former showing upregulated pro-inflammatory genes and downregulated cell metabolism pathways, while the latter showed downregulation of cell metabolism without any inflammatory signals.

JOURNAL OF TRANSLATIONAL MEDICINE (2023)

Review Cell Biology

Necroptosis in Organ Transplantation: Mechanisms and Potential Therapeutic Targets

Yajin Zhao, Kimberly Main, Tanroop Aujla, Shaf Keshavjee, Mingyao Liu

Summary: Organ transplantation is the only treatment option for end-stage organ dysfunction, but it faces various limitations. This study reveals the mechanisms of necroptosis in organ transplantation and identifies potential targeted drugs.
Article Gastroenterology & Hepatology

Diffuse Panbronchiolitis in a Patient With Ulcerative Colitis Treated With Ustekinumab

Meghan Marmor, Gerald Berry, Rishi Raj

ACG CASE REPORTS JOURNAL (2023)

暂无数据